Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Nicorette QuickMist
Nicotine 13.6mg/mL
Oral spray
Johnson & Johnson (New Zealand) Limited
McNeil AB, Helsingborg, Sweden
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
pms-Bosentan
Bosentan monohydrate 62.5mg
Film coated tablet
AFT Pharmaceuticals Limited
Genvion Corporation, Winnipeg, Canada
Pharmascience Inc, St Laurent, Canada
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
pms-Bosentan
Bosentan monohydrate 125mg
Film coated tablet
AFT Pharmaceuticals Limited
Genvion Corporation, Winnipeg, Canada
Pharmascience Inc, St Laurent, Canada
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Relenza Rotadisk
Zanamivir 5mg
Powder for inhalation
GlaxoSmithKline (NZ) Limited
Glaxo Wellcome Production, Evreux, France
GlaxoSmithKline Australia Pty Limited, Melbourne, Australia
|
Dated this 29th day of October 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz